PPAR Regulation of Inflammatory Signaling in CNS Diseases. - Wikidata - awgldk - TriplyDB

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

http://www.wikidata.org/entity/Q37231755

about

Neuroinflammation in Alzheimer's disease PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE).Novel method of monitoring trace cytokines and activated STAT molecules in the paws of arthritic mice using multiplex bead technology.Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma Endocannabinoids in synaptic plasticity and neuroprotection.Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARδ) in mice leads to increased susceptibility to diet-induced obesity.Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia.Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice.PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury.Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.Radiation-induced cognitive impairment--from bench to bedside In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.The Neurogenic Potential of Astrocytes Is Regulated by Inflammatory Signals.Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease.Immunomodulatory and anti-inflammatory effects of chondroitin sulphate.Role of PPARs in Radiation-Induced Brain Injury.Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity: a common denominator mapping chronic diseases.Agonistic induction of PPARγ reverses cigarette smoke-induced emphysema.Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders.Radiation-induced brain injury: A review The balancing act - PPAR-γ's roles at the maternal-fetal interface.Molecular, Cellular and Functional Effects of Radiation-Induced Brain Injury: A Review PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Molecular pathways: radiation-induced cognitive impairment.PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.PPAR activation induces M1 macrophage polarization via cPLA₂-COX-2 inhibition, activating ROS production against Leishmania mexicana.Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.

P2860

Q27004226-CB125687-C427-4137-A58A-CF1EF3F40DAF Q28069549-ED65C8CC-27CD-4BC5-B1DD-16E25B8EA17A Q28394506-E2108ED3-286B-43FD-AAC2-6A1371214D48 Q28536366-A3C4497B-B6EE-45EA-A5A3-B692A32715AF Q33708001-86183161-BCF6-4B57-8E63-F94B50FA569A Q33728403-CAB59397-1518-4D98-989B-9672A59DE618 Q33745759-DDF9D479-C43D-4EC3-984A-04A5E5BB68E2 Q33748280-18D607E0-0C07-4F72-8220-4B4E23826C2F Q34084682-DBCAA3D2-40E3-441F-9B50-705FCA466A69 Q34391171-F2749725-08AE-4BBC-BC3D-6E08E9F8B2A5 Q34451684-3FFD4B04-D983-47C7-B2F4-2D9FB4886880 Q34612008-A1614C14-4518-4FAB-9F74-00D01EB26014 Q34636570-A545893B-6E5B-441E-8B7A-EB6007B6725F Q34970533-B8537253-751F-485A-8CA1-E29CA5976101 Q35027487-90353486-461B-4FB4-B048-58580A7308EA Q35101529-473C3542-CBBA-4217-9BE7-7B0992B17AA6 Q35113069-8613EC7D-6705-4DFD-8522-5C155B71CB62 Q35193317-3A37D443-1B7A-42AD-A399-BD21329DF6C5 Q35601542-3CBF6936-F285-4446-933F-8AB1BCB7FC1B Q35864188-0A3C6631-1D45-4A05-ABFD-56D58C45C999 Q36298402-C757EAE7-F6F2-4C33-A869-192DC4CF5CBF Q36344693-6F9F1E77-CD03-4B6A-A8DA-ABCB0B4955BC Q36509809-9F6C530C-F6E2-452C-A53A-E840EF1441C0 Q37075674-BBDEDB36-E7A3-43B0-8AB6-B461ADC29D5E Q37188527-15BA6692-8C41-46EA-A08C-A1679BCC998D Q37310621-70C30DD8-505E-4620-881A-402DF66AD9F5 Q37356420-C6BB8A52-66FD-42E9-A19A-BD09818C2D27 Q37578322-45C39131-4467-471D-91C8-AA6C2793A89F Q37602184-CE68B99C-5402-4A50-87F9-E05FA3B8A8EB Q37690079-D2185997-CD05-4858-A5EA-0D4A007E3778 Q37995569-66E6F4F0-BCAB-498D-8089-FD6FD70B2004 Q38029608-6DB9498E-643D-4E8A-9723-48E257DF0ACD Q38283155-7C7D8706-F0AD-4EF8-80BB-B91A9719A9A3 Q38648782-6B4BB8DC-E40E-40B7-80E2-571420A2A186 Q38862023-F5CDDAB9-B8EC-4425-979F-32A70DB56A09 Q39042377-BA28E522-5DAA-438F-8691-6B193AE0D0DC Q40321538-A8BB065A-69F2-4822-9AFA-67B93C5BC6E9 Q42952425-E6AE64EC-DABA-4BC9-8DE0-383CC63CE2C1 Q43226769-75C7C3EE-4740-43B7-BE6D-2BEE36A8ECFA Q44851919-2C562D0A-6B18-4F43-AEF4-CE65AE088018

P2860

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

http://www.wikidata.org/entity/Q37231755

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@en

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@nl

type

label

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@en

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@nl

prefLabel

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@en

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@nl

P1433

Q37231755-CBD40C35-180B-4DC2-A363-A64E3817EFF6

P1476

Q37231755-59D366E8-F54B-4034-91C3-38912189D8BF

P2093

Q37231755-4C7043C2-C04A-4795-861F-8F499C556DE7

Q37231755-66DD741B-4593-4D62-AB8E-6659C6421D53

Q37231755-939EBE88-2691-4E69-BA0A-A6010E8CE39D

Q37231755-AC460424-44AE-42D4-A40A-868A15436A60

P2860

Q37231755-01E1D1F0-20E2-45DE-A481-E4C536086C31

Q37231755-024A9747-303D-4B7E-AFE9-0C56E9DA8DD8

Q37231755-064BC293-EF7B-440A-8B4D-95161AC6B957

Q37231755-0CE04A94-851F-4510-BA0A-5C33E7FB3562

Q37231755-0EF97FAE-61D2-4AD9-8152-611EAF593402

Q37231755-176B4660-973E-4F1A-8B4F-247FB377F3AF

Q37231755-17E9C3F6-4C1A-4CB3-8ACB-96922CDD5931

Q37231755-19CCCC5E-6624-4267-AD1F-DAA5798E68F6

Q37231755-1B0C27CF-490F-445D-8171-8C1123236B81

Q37231755-22A4FB0C-7A6E-4C80-8D68-E66FF31632DE

P304

Q37231755-A31A4B12-6AB8-449C-83C4-A9AA8CC1392F

P31

Q37231755-D94E11C1-19D4-45A5-BA3B-1D0C7819DD51

P356

Q37231755-23B7386C-2FEC-4E03-AF97-120382D0EBC4

P478

Q37231755-B1EC1AD8-91A6-4B99-92B9-6295581C889D

P577

Q37231755-0DF21C14-DFE8-422A-8CA2-C72FD47CBE1D

P5875

Q37231755-206E0ACC-D4BF-40D2-9237-627319BAF55D

P698

Q37231755-301369D3-0405-4450-855A-C962DDD1A1ED

P921

Q37231755-A4C49707-99DA-474B-91C4-5344C5F70FE1

P932

Q37231755-9395C0F0-1798-4C27-A532-A4F21E745EAA

P356

P1433

P1476

PPAR Regulation of Inflammatory Signaling in CNS Diseases.

@en

P2093

John J Bright

http://www.w3.org/2001/XMLSchema#string

Saravanan Kanakasabai

http://www.w3.org/2001/XMLSchema#string

Sharmistha Chakraborty

http://www.w3.org/2001/XMLSchema#string

Wanida Chearwae

http://www.w3.org/2001/XMLSchema#string

P2860

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

Regulation of interleukin 12 p40 expression through an NF-kappa B half-site

Effect of pioglitazone treatment in a patient with secondary multiple sclerosis

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

A unified nomenclature system for the nuclear receptor superfamily

Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro

P304

658520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2008/658520

http://www.w3.org/2001/XMLSchema#string

P478

2008

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23140947

http://www.w3.org/2001/XMLSchema#string

P698

18670616

http://www.w3.org/2001/XMLSchema#string

P921

P932

2490815

http://www.w3.org/2001/XMLSchema#string